Taguin, Felipe M.

HRN: 22-12-39  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2022
CEFTAZIDIME 1GM (VIAL)
10/30/2022
11/06/2022
IVTT
1g
Q8
Pulmonary Infection/ Infiltrates
Waiting Final Action 
10/30/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/30/2022
11/06/2022
IVTT
600mg
Q8
Pulmonary Infection/ Infiltrates
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: